![](/assets/avatars/avatar-publication-b82d19bb2e3dcd30febf5ea64511884facd2f6698b7de16227b3e2c24ee35931.png)
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.
![](/assets/famfamfam_silk/page_white_go-0c1d6fc52b0accc2a26565737a1bfabe02e1980e768701c88b225d100de96dad.png)
![](/assets/famfamfam_silk/script_go-0c2a24c19bb933b67d50a0308fce8173ab85f681ae3cbbb91060e34cdf5c6254.png)
AIM: To identify gene variants responsible for anthracycline-induced cardiotoxicity. PATIENTS & METHODS: Polymorphisms of the NADPH oxidase subunits and of the anthracycline transporters ABCC1, ABCC2 and SLC28A3 were genotyped in elderly patients (61-80 years) treated for aggressive CD20(+) B-cell lymphomas with CHOP-14 with or without rituximab and followed up for 3 years. RESULTS: The accumulation of RAC2 subunit genotypes TA/AA among cases was statistically significant upon adjustment for gender, age and doxorubicin dose in a multivariate logistic regression analysis (OR: 2.3, p = 0.028; univariate: OR: 1.8, p = 0.077). RAC2 and CYBA genotypes were significantly associated with anthracycline-induced cardiotoxicity in a meta-analysis of this and a similar previous study. CONCLUSION: Our results support the theory that NADPH oxidase is involved in anthracycline-induced cardiotoxicity. Original submitted 9 July 2014; Revision submitted 19 December 2014.
PubMed ID: 25823784
Projects: GLA - German Lymphoma Alliance
Publication type: Not specified
Journal: Pharmacogenomics
Human Diseases: B-cell lymphoma
Citation: Pharmacogenomics. 2015;16(4):361-72. doi: 10.2217/pgs.14.179.
Date Published: 1st Apr 2015
Registered Mode: by PubMed ID
![help](/assets/famfamfam_silk/information-ff9c48d8c2d063932c7aadd5e15ddfdc76b7111bf0715f3a192bba26df2c531c.png)
Views: 3140
Created: 17th Apr 2019 at 13:49
Last updated: 7th Dec 2021 at 17:58
![help](/assets/famfamfam_silk/information-ff9c48d8c2d063932c7aadd5e15ddfdc76b7111bf0715f3a192bba26df2c531c.png)
None